Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene.

作者: Gerald W. Verhaegh , Adrie van Bokhoven , Frank Smit , Jack A. Schalken , Marion J. G. Bussemakers

DOI: 10.1074/JBC.M006293200

关键词: TransfectionMolecular biologyGeneLNCaPProstate cancerCell cultureHigh-mobility groupSequence analysisBiologyPromoter

摘要: Recently, we have described a novel gene,DD3, which is one of the most prostate cancer-specific genes to date (Bussemakers, M. J. G., van Bokhoven, A., Verhaegh, G. W., Smit, F. P., Karthaus, H. M., Schalken, Debruyne, J., Ru, N., and Isaacs, W. B. (1999) Cancer Res. 59, 5975–5979). The expression DD3 indicates that theDD3 gene promoter promising tool for treatment cancer. To identify elements are responsible DD3, isolated characterized promoter. Sequence analysis 5′-flanking region was performed several promoter-human growth hormone reporter constructs were prepared, transiently transfected in DD3-positive cell line LNCaP DD3-negative lines. Using 500-base pair construct, could detect activity cells, not affected by increasing size constructs. Truncated constructs, however, showed an increased transcriptional activity, suggesting presence silencer negatively regulates DD3. DNase-I footprint analysis, using nuclear extracts from revealed three DNase-I-protected areas within proximal We show high mobility group I(Y) protein binds recruits another, yet unidentified, cells.

参考文章(37)
G. J. Van Steenbrugge, W. M. Van Weerden, C. M. A. De Ridder, J. C. Romijn, C. L. Verdaasdonk, F. H. Schröder, T. H. Van Der Kwast, Development of seven new human prostate tumor xenograft models and their histopathological characterization. American Journal of Pathology. ,vol. 149, pp. 1055- 1062 ,(1996)
Lori J. Sokoll, Daniel W. Chan, PROSTATE-SPECIFIC ANTIGEN: Its Discovery and Biochemical Characteristics Urologic Clinics of North America. ,vol. 24, pp. 253- 259 ,(1997) , 10.1016/S0094-0143(05)70370-0
W. D. W. Heston, W. R. Fair, R. S. Israeli, C. T. Powell, Molecular Cloning of a Complementary DNA Encoding a Prostate-specific Membrane Antigen Cancer Research. ,vol. 53, pp. 227- 230 ,(1993)
J Ye, P Ghosh, M Cippitelli, J Subleski, K J Hardy, J R Ortaldo, H A Young, Characterization of a silencer regulatory element in the human interferon-gamma promoter. Journal of Biological Chemistry. ,vol. 269, pp. 25728- 25734 ,(1994) , 10.1016/S0021-9258(18)47308-5
S. Pierrou, M. Hellqvist, L. Samuelsson, S. Enerbäck, P. Carlsson, Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. The EMBO Journal. ,vol. 13, pp. 5002- 5012 ,(1994) , 10.1002/J.1460-2075.1994.TB06827.X
Renee Garcia-Arenas, Julie DaVolio, Ming Fong Lin, Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells. Cancer Research. ,vol. 52, pp. 4600- 4607 ,(1992)
Jens Dannull, Randhir Kaboo, Jean B. deKernion, Arie S. Belldegrun, Cho-Lea Tso, Kiarash Michel, Yiming Xie, Shen Pang, Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen Cancer Research. ,vol. 57, pp. 495- 499 ,(1997)
R F Selden, K B Howie, M E Rowe, H M Goodman, D D Moore, Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Molecular and Cellular Biology. ,vol. 6, pp. 3173- 3179 ,(1986) , 10.1128/MCB.6.9.3173
Rosetta Martiniello-Wilks, Juanita Garcia-Aragon, Mirella M. Daja, Peter Russell, Gerald W. Both, Peter L. Molloy, Linda J. Lockett, Pamela J. Russell, In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors. Human Gene Therapy. ,vol. 9, pp. 1617- 1626 ,(1998) , 10.1089/HUM.1998.9.11-1617
S. L. Parker, T. Tong, S. Bolden, P. A. Wingo, Cancer statistics, 1997 CA: A Cancer Journal for Clinicians. ,vol. 47, pp. 5- 27 ,(1997) , 10.3322/CANJCLIN.47.1.5